• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present invention relates to a hollow fiber membrane made of ethylene-vinyl alcohol polymer and a production method thereof. According to the present invention, in the hollow fiber membrane made of ethylene-vinyl alcohol polymer, composed of a dense layer present on the inner surface and a porous layer present in addition to the dense layer, the porosity is 60 to 90%, and in water-based systems The overall mass transfer coefficient of myoglobin is at least 0.003 cm / min, and the rejection rate of albumin in the bovine blood system is at least 97%. EVA hollow fiber membranes are useful for hemodialysis membranes, hemodialysis filtration membranes, blood filtration membranes and continuous blood filtration membranes.
    公开号:KR20010078245A
    申请号:KR1020010004831
    申请日:2001-02-01
    公开日:2001-08-20
    发明作者:가끼우찌도모끼；세끼구찌고지；스에히로다께시；나까지슈헤이；마쯔모또요이찌；다까이마사또；스고노조무；쯔루따히또시
    申请人:나카무라 하사오；가부시키가이샤 구라레；
    IPC主号:
    专利说明:

    Hollow fiber membrane and its manufacturing method {HOLLOW FIBER MEMBRANE AND PROCESS FOR PRODUCING THE SAME}
    [1] The present invention relates to a hollow fiber membrane made of an ethylene-vinyl alcohol polymer (hereinafter, "ethylene-vinyl alcohol" is simply referred to as "EVA" and a "hollow fiber membrane composed of an EVA polymer" is represented by an "EVA hollow fiber membrane" and a method of manufacturing the same. It is about. Specifically, the present invention relates to an EVA hollow fiber membrane and a EVA hollow fiber membrane production method used for blood purification, such as hemodialysis membrane, hemodialysis filtration membrane, hemofiltration membrane and continuous blood filtration membrane.
    [2] Since the hollow fiber membranes are excellent in hydrophilicity, hollow fiber membranes made of EVA polymer have been widely used as various separators for industrial, medical and other uses (Japanese Patent Laid-Open Publication No. H-42208). In particular, the hollow fiber membrane has been widely used in medical applications as a material having excellent biocompatibility and chemical stability and hardly eluting. Such representative applications include, for example, hemodialysis filtration membranes.
    [3] Japanese Patent Publications No. 58-36602, Japanese Patent Publication Nos. 58-45239 and 5-42208 are analogous hollow fiber membranes of high dissimilarity and permeability, which are dense to impart permeability and fractionation to the inner surface. It is proposed that the membrane has an asymmetric structure composed of a layer and a porous layer supporting the dense layer.
    [4] Recently, not only low-molecular weight substances (molecular weight: less than 1000) such as urea and creatine, but also intermediate molecular weights represented by, for example, β 2 -microglobulin (molecular weight: 11800, hereinafter simply referred to as "β 2 -MG"). Or it is highly desirable to remove a high molecular weight substance (molecular weight: about 1000-40000) by dialysis. EVA hollow fiber membranes having the asymmetric structure have been developed mainly for the purpose of removing low molecular weight substances such as urea and creatine contained in blood. Thus, EVA hollow fiber membranes are not satisfactory enough to remove materials of medium or high molecular weight.
    [5] It is an object of the present invention to provide an EVA hollow fiber membrane which is excellent in removing substances of medium molecular weight or high molecular weight and has little loss of albumin.
    [6] Another object of the present invention is to provide a method for producing a hollow fiber membrane.
    [7] These and other objects of the present invention will become apparent from the following description.
    [8] According to the invention, in the hollow fiber membrane made of ethylene-vinyl alcohol polymer, consisting of a dense layer present on the inner surface and a porous layer present in addition to the dense layer, the porosity is 60 to 90%, and myoglobin in water-based The overall mass transfer coefficient of is at least 0.003 cm / min and the rejection rate of albumin in the bovine serum system is at least 97%.
    [9] In a preferred embodiment of the EVA hollow fiber membrane, the removal rate of urea in a bovine serum system per 1.6 m 2 membrane area is greater than or equal to 175 mL / min based on a blood flow rate of 200 mL / min and a dialysis flow rate of 500 mL / min, and β 2 -microglobulin Removal rate is at least 35 mL / min.
    [10] Further, in another preferred embodiment of the EVA hollow fiber membrane, the hollow fiber membrane has a pore area ratio of 30% or more at a depth of 1 m from the inner surface, and the diameter of the nozzle forming the dense layer is 5 to 50 nm.
    [11] The present invention also provides a method for producing a hollow fiber membrane made of an ethylene-vinyl alcohol polymer, which contains ethylene-vinyl alcohol and a solvent from a double regeneration nozzle in which a hollow former is poured into a double annular nozzle. And extruding the dope to form a film (the dope is transparent and uniform at high temperature but phase separation occurs when the temperature is lowered), passing the hollow fiber membrane extruded from the dual regeneration nozzle through air, and thereafter, Introducing a hollow fiber membrane into the water bath, the temperature of the dope forming the membrane (T D , ° C.), the phase separation temperature (LST), and the temperature of the air passing through the hollow fiber membrane extruded from the dual regeneration nozzle (T A , ° C) satisfy the following relation:
    [12] 5 ≤ LST ≤ 40,
    [13] T D ≤ LST + 20, and
    [14] T A ≤ LST.
    [15] In the EVA hollow fiber membrane of the present invention, the porous layer present in the layers other than the dense layer has a fairly large hole. The shape of the hole may be arbitrarily selected within the limit that the influence on the permeability is small. The shape may be a network structure and large pores and anything similar.
    [16] Since the porosity of the EVA hollow fiber membrane of the present invention is 60% or more, the permeability of the medium molecular weight or high molecular weight material is high. In addition, since the porosity is 90% or less, its mechanical strength is high. The porosity is preferably 65 to 85%.
    [17] Porosity is calculated by the formula:
    [18] [Porosity] (%) = {(W W -W D ) / ρ W } / {W D / ρ E- (W W + W D ) / ρ W } × 100,
    [19] Where W W is the weight of the water-containing membrane, W D is the dry membrane weight, ρ W is the specific gravity of water, and ρ E is the specific gravity of EVA.
    [20] From the standpoint of increasing the removal efficiency of medium molecular weight or high molecular weight materials, the overall mass transfer coefficient for myoglobin of the EVA hollow fiber membranes in water is at least 0.003 cm / min, preferably at least 0.005 cm / min.
    [21] From the standpoint of suppressing the outflow of proteins useful to the body to a minimum level, the inhibition rate against albumin of the EVA hollow fiber membrane in the bovine serum system is 97%, preferably 98% or more.
    [22] In addition, from the viewpoint of increasing the removal efficiency of low molecular weight substances, the removal rate of urea in a bovine serum system per 1.6 m 2 of membrane area is preferably 175 mL / min, based on a blood flow rate of 200 mL / min and a dialysis flow rate of 500 mL / min. More preferably 180 mL / min, even more preferably 185 mL / min or more.
    [23] From the viewpoint of increasing the removal efficiency of the medium molecular weight or high molecular weight material, the removal rate of β 2 -MG in the serum system of 1.6 m 2 per membrane area is preferably 35 based on the blood flow rate 200 mL / min and the dialysis flow rate 500 mL / min. mL / min, more preferably 40 mL / min, even more preferably at least 45 mL / min.
    [24] In the present invention, the overall mass transfer coefficient, the inhibition rate of albumin, the removal rate of urea and the removal rate of β 2 -MG for myoglobin can be determined according to the evaluation criteria for dialysis device characteristics [author T. Satoh et al. : Functions and Adaptation of Various Blood Purification Methods- Performance Evaluation and Function Classification of Blood Purifiers, Tosekikaishi , issued by Nippon Toseki Igakukai, 29 (8), 1231-1245, 1996].
    [25] The overall mass transfer coefficient for myoglobin is calculated from the removal rate determined in the water system (filtration flow rate: Q F '= 0 mL / min / m 2 ) according to the following equation:
    [26] K (total mass transfer coefficient for myoglobin) (cm / min) =
    [27] Q B / A × (1-Z) × ln (1-E × Z) / (1-E)
    [28] [Wherein E = CL / Q B and Z = Q B / Q D , CL is the removal rate (mL / min), Q B is the flow rate at the blood side inlet (mL / min), Q D is at the inlet side Flow rate (mL / min)].
    [29] The inhibition rate of albumin, the removal rate of urea and the removal rate of β 2 -MG are determined in bovine serum system (Q F '= 10 mL / min / m 2 ).
    [30] In the EVA hollow fiber membrane of the present invention, in view of high permeability to medium molecular weight or high molecular weight material, the rate of pore area is 30% or more at a depth of 1 μm from the inner surface, and the dense layer of the inner surface It is preferable that the diameter of the nozzle for forming the film is 5 to 50 nm. The porosity is preferably 35% or more, and more preferably the diameter of the nozzle forming the dense layer of the inner surface is in the range of 5 to 45 nm.
    [31] The porosity can be determined by performing image analysis of the micro photograph (magnification: 60000) of the EVA hollow fiber membrane. Specifically, the hole existing in the microphotograph of the cross section of the hollow fiber membrane at 1 μm from the inner surface was evenly painted with black ink, and then the hole area S 1 and the total area S 2 were determined by an image processor, and then the opening was made based on the following equation. Calculate the power to get:
    [32] [Porosity] (%) = (S 1 / S 2 ) × 100.
    [33] The nozzle consists of dense particles of a high molecular compound. The nozzle is a fibrous fiber or particle aligned in the longitudinal direction of the hollow fiber membrane when the inner surface is observed with an atomic force microscope.
    [34] In the EVA hollow fiber membrane, the dense layer refers to an area having a pore size of 5 to 50 nm. The pore size of the dense layer is determined by observing the surface of the dense layer, that is, the inner surface of the EVA hollow fiber membrane, with an electron microscope (magnification: 60000). .
    [35] In view of causing less defects in the dense layer and giving a high rejection rate of albumin and a high permeability of the intermediate molecular weight or high molecular weight material, the thickness of the dense layer is preferably in the range of 0.1 to 2 μm. In view of ensuring a higher permeability of the intermediate molecular weight and higher molecular weight material, the thickness of the dense layer is preferably 0.1 to 1 m.
    [36] The shape of the EVA hollow fiber membrane is like a hollow tube. In view of ensuring the thermal stability and mechanical strength and the removal efficiency of the medium molecular weight or high molecular weight material, the film thickness of the EVA hollow fiber membrane is 3 to 2000 μm, preferably 10 to 1000 μm, more preferably 10 to 400 μm. to be. The outer diameter of the EVA hollow fiber membrane is usually 40 to 5000 µm, preferably 40 to 3000 µm, more preferably 100 to 1000 µm.
    [37] Next, the EVA hollow fiber membrane manufacturing method is demonstrated. First, the EVA polymer is dissolved in a solvent to make a dope to form a film.
    [38] The EVA polymer can be any of an irregular interpolymer of ethylene and vinyl alcohol, a block copolymer and a graft copolymer. In view of ensuring mechanical strength and biocompatibility during wetting, the EVA polymer preferably has an ethylene content of 10 to 60% on a molar basis and a degree of saponification of at least 95% on a molar basis. The EVA polymer may be copolymerized with a copolymerizable monomer such as methacrylic acid, vinyl chloride, methyl methacrylate or acrylonitrile at 15% or less on a molar basis.
    [39] Solvents that dissolve the EVA polymer include dimethylsulfoxide (hereinafter referred to as DMSO), N, N-dimethylacetamide (hereinafter referred to as DMAc), N-methylpyrrolidone (hereinafter referred to as NMP), and such Mixed solvents including compounds. From the viewpoint of easily obtaining EVA hollow fiber membranes having desired membrane structure and physical properties in the present invention and having relatively low toxicity, DMSO is preferred among them.
    [40] The concentration of the EVA polymer in the dope forming the film is preferably 5 to 50% by weight, more preferably 10 to 30% by weight. If the concentration is too high, it tends to lower the permeability of the medium molecular weight or high molecular weight material. In addition, when the concentration is too low, the viscosity of the dope is lowered, and therefore, there is a tendency to lower the heat resistance of the hollow fiber membrane and lower the mechanical strength.
    [41] In order to control the phase separation temperature and viscosity, additives may be added to the dope for film formation. The additive is water; Alcohols such as methanol, ethanol, glycerol, ethylene glycol and diethylene glycol; Ketones such as acetone and methyl ethyl ketone; High molecular compounds such as polyethylene glycol, chitosan, chitin, dextran and polyvinyl pyrrolidone; Salts such as lithium chloride, sodium chloride, calcium chloride, lithium acetate, sodium sulfate and sodium hydroxide; And similar things. Of these, water having no volatility and toxicity is preferable. It is also preferred to use lithium salts such as lithium chloride and lithium acetate in order to form the desired dense layer on the inner surface.
    [42] The dope for forming the film is transparent and uniform at high temperatures, but phase separation occurs at lower temperatures. The temperature at which phase separation occurs (hereinafter referred to simply as "LST") is preferably set to 5 < LST < 40 (° C). In order to adjust the LST to the above range, the concentration of the additive in the dope for forming the film is preferably 20% or less by weight. If the concentration is too high, it is difficult to obtain the desired LST, and sometimes the EVA polymer does not dissolve in the dope. LST becomes like this. Preferably it is the range of 10-40 degreeC, More preferably, it is the range of 15-40 degreeC. Herein, LST means a temperature at which the dope for forming a film becomes cloudy when the temperature is lowered from 90 ° C to 1 ° C per minute.
    [43] In order to obtain an EVA hollow fiber membrane having the film structure and physical properties of the object required by the present invention, a dry-wet method is preferable as a method for forming the film. According to the dry-wet method, a dope for film formation is blown into the air from a double play nozzle, by pouring a hollow former on the inner surface of the double play nozzle; Solidification of the extruded product to form a dense layer from the inner surface; The EVA hollow fiber membrane is then obtained by introducing the extruded product into a water bath. In the case of membranes made by a wet process consisting of directly extruding dope for film formation in a water bath to solidify the extruded product, a dense layer is likely to form on the outer surface as solidification takes place on the outer surface as well.
    [44] Between the temperature (T D) of the dope for forming a film, LST and the temperature of the air that passes through the extruded product (T A) is to satisfy the relationship D ≤ LST + 20, and T T A ≤ LST. If T D , LST and T A satisfy the conditions T D > LST + 20 and T A > LST, there is a tendency to lower the blocking rate of albumin and make film formation difficult. The above-mentioned air temperature T A is more preferably LST-5 ° C or lower.
    [45] Since it is necessary to accelerate the solidification to form the desired dense layer on the inner surface, it is preferable to use a solution having the function of solidifying the EVA polymer as the hollow former. As long as the hollow former has the function of solidifying the EVA polymer and is miscible with the solvents mentioned above, the hollow former can be used without any limitation. As the hollow former, a medium which is generally soluble in water is used. By way of example, the hollow former may be water; Mixtures of water and solvents such as DMSO, DMAc, NMP, and alcohols that are soluble in water; Similar ones are included. In addition, aqueous solutions containing inorganic salts such as lithium chloride, sodium chloride, calcium chloride, lithium acetate, sodium sulfate or sodium hydroxide can in particular be used as hollow formers.
    [46] Generally, the EVA hollow fiber membranes are sent to wet heat treatment after solidification is complete. The temperature during the wet heat treatment is generally in the range from 40 to 80 ° C, preferably 55 to 70 ° C. If the temperature during the wet heat treatment is lower than the above range, it tends to lower the storage stability and physical properties of the dimensions and performance after drying. In addition, when the temperature exceeds the above range, it causes a change in the film structure and properties. Wet heat treatment is usually performed by passing the EVA hollow fiber membrane through hot water, which is a cleaning solution of the hollow fiber membrane. Wet heat treatment and cleaning need not be performed simultaneously. It is also possible to carry out a wet heat treatment consisting of washing the membrane after passing the EVA hollow fiber membrane with saturated steam. Conversely, it is also possible to perform the cleaning first and then the wet heat treatment. In any case, from the viewpoint of the simplification of the method, it is preferable to simultaneously perform the wet heat treatment and the washing.
    [47] The wet EVA hollow fiber membrane is immersed in a water-miscible volatile organic solvent to replace water present on the surface or inside the membrane together with the organic solvent and dried under normal pressure and reduced pressure. In this case, it is preferable to use a lower aliphatic alcohol having 1 to 5 carbon atoms or ketone as the organic solvent. Preferred organic solvents include, for example, methanol, ethanol, amyl alcohol, acetone, methyl ethyl ketone, diethyl ketone and the like. The temperature at the time of drying is 55 degrees C or less, Preferably 50 degrees C or more is good. Further, the water vapor pressure is 0.0027 MPa (20 mm Hg), preferably 0.0014 MPa (10 mmHg) or less. Under these conditions, the EVA hollow fiber membranes can be dried while maintaining their physical properties in the wet state.
    [48] After drying, the EVA hollow fiber membrane is sent to a dry heat treatment step. The temperature during the dry heat treatment is preferably in the range from 30 to 70 ° C, preferably from 30 to 65 ° C. If the temperature exceeds the above range during the dry heat treatment, there is a tendency to produce a change in film structure and properties. In addition, if the temperature is lower than the above range, it is difficult to achieve sufficient heat fixation, and therefore, the dimensional stability and storage stability tend to be deteriorated. It is preferable that in the dry heat treatment, the atmospheric water vapor pressure is about 0.0080 MPa (60 mmHg) or less. Do. If the water vapor pressure exceeds the upper limit, the adsorption of water molecules into the EVA polymer occurs, causing a change in membrane structure and physical properties due to desorption of water molecules when the EVA polymer is exposed to the room temperature atmosphere after the dry heat treatment.
    [49] The dried EVA hollow fiber membrane obtained by the above-described method has excellent dimensional stability in a dry state and is easy to move. If the EVA hollow fiber membrane dried prior to use is rewet with water or physiological saline, the structure and physical properties before drying are reproduced.
    [50] Example
    [51] The present invention will be explained in more detail by the following examples, but the present invention is not limited to the following examples.
    [52] Example 1
    [53] EVA polymer (trade name: EVAL EC-F100A, commercially available from Kuraray Co., Ltd, 15%, DMSO 73%, water with a ethylene content of 32% and a saponification degree of 99% in molar ratio to make dope for film formation) 10% and 2% lithium chloride (based on weight ratio) are dissolved by heating at 90 ° C. LST of the produced dope was 28 degreeC. Water is poured into the inside of the double playing nozzle and the dope is extruded from the double playing nozzle at 40 ° C. The extruded solution passes air at 15 ° C. and enters the water bath. Thereafter, as usual for making dry hollow fiber membranes, water washing, wet heat treatment, drying, and dry heat treatment are performed.
    [54] The produced hollow fiber membrane was 265 micrometers in outer diameter, 175 micrometers in inner diameter, and 45 micrometers in thickness. The conditions of film formation are shown in Table 1, and the structure and physical properties of the film observed by electron microscope (magnification: 60000) and atomic force microscope are shown in Table 2.
    [55] Example 2
    [56] To make a dry hollow fiber membrane, the same dope was used for film formation as in Example 1, and the film was made under the film formation conditions shown in Table 1. Conditions other than those posted in Table 1 were the same as in Example 1.
    [57] The obtained hollow fiber membrane was 265 micrometers in outer diameters, 175 micrometers in inner diameters, and 45 micrometers in thickness. The structure and physical properties of the membrane are shown in Table 2.
    [58] Example 3
    [59] EVA polymer (Kuraray Co., Ltd, commercially useful trade name: EVAL ES-G110A) 15%, DMSO 78%, water 5%, and lithium chloride 2% (weight ratio) A dope for film formation was made, and a film was formed using this dope under the film forming conditions shown in Table 1 to make a dry hollow fiber film. Conditions other than those posted in Table 1 were the same as in Example 1.
    [60] The obtained hollow fiber membrane was 265 micrometers in outer diameters, 175 micrometers in inner diameters, and 45 micrometers in thickness. The structure and physical properties of the membrane are shown in Table 2.
    [61] Example 4
    [62] 16% EVA polymer with 47% ethylene content and 99% saponification in a molar ratio, 83% DMSO and 1% water by weight to form a dope for film formation and to form a dry hollow fiber membrane shown in Table 1 The film was made using the above dope under conditions. Conditions other than those shown in Table 1 were the same as in Example 1.
    [63] The obtained hollow fiber membrane was 265 micrometers in outer diameters, 175 micrometers in inner diameters, and 45 micrometers in thickness. The structure and physical properties of the membranes are shown in Table 2.
    [64] Comparative Example 1
    [65] Membrane formation shown in Table 1 to make dope for film formation with 15% EVA polymer with 32% ethylene content and 99% saponification degree, 84% DMSO and 1% water by weight (by weight) in molar ratio and to make dry hollow fiber membrane The film was made using the above dope under the conditions of. Conditions other than those shown in Table 1 were the same as in Example 1.
    [66] The obtained hollow fiber membrane was 265 micrometers in outer diameters, 175 micrometers in inner diameters, and 45 micrometers in thickness. The structure and physical properties of the membranes are shown in Table 2.
    [67] Comparative Examples 2 and 3
    [68] In order to make a dry hollow fiber membrane, each film was made under film forming conditions as shown in Table 1, using the same dope for film formation as in Comparative Example 1. Conditions other than those shown in Table 1 were the same as in Example 1.
    [69] Each of the obtained hollow fiber membranes was 265 micrometers in outer diameter, 175 micrometers in inner diameter, and 45 micrometers in thickness. The structure and physical properties of the membranes are shown in Table 2.
    [70] Comparative Example 4
    [71] To make a dope for film formation, and to make a dry hollow fiber membrane with 15% EVA polymer with a ethylene content of 32% at a molar ratio of 99%, 63% DMSO, 20% water and 2% lithium chloride (by weight). The film was made using the above dope under the film formation conditions shown in FIG. Conditions other than those shown in Table 1 were the same as in Example 1.
    [72] Each of the obtained hollow fiber membranes was 265 micrometers in outer diameter, 175 micrometers in inner diameter, and 45 micrometers in thickness. The structure and physical properties of the membranes are shown in Table 2.
    [73] Comparative Example 5
    [74] To make a dry hollow fiber membrane, the film was made under the film forming conditions shown in Table 1 using the same dope for film formation as in Example 3. Conditions other than those shown in Table 1 were the same as in Example 1.
    [75] Each of the obtained hollow fiber membranes was 265 micrometers in outer diameter, 175 micrometers in inner diameter, and 45 micrometers in thickness. The structure and physical properties of the membranes are shown in Table 2.
    [76] According to the present invention, an EVA hollow fiber membrane having a dense layer on the inner surface and consisting of a porous layer in addition to the dense layer is formed, which exhibits high transmission rate for myoglobin and medium or high molecular weight material and high blocking rate for albumin.
    [77] same
    [78] The technology may recognize or identify many equivalents, such as specific embodiments of the invention described herein, using simple routine experimentation. Such equivalents are intended to be included within the scope of this invention as described in the following claims.
    [79] Film formation condition ExamplePhase separation temperature [℃]Doping temperature [℃]Pass air temperature [℃]Hollow Forming Agent 1234282829204030303015201015Water DMSO / water = 15/85 (weight ratio) Water DMSO / water = 30/70 (weight ratio) Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 411158293020208560(Wet) (Wet)Nitrogen Water
    [80]
    [81] EVA hollow fiber membranes are useful for hemodialysis membranes, hemodialysis filtration membranes, blood filtration membranes and continuous blood filtration membranes.
    权利要求:
    Claims (4)
    [1" claim-type="Currently amended] There is a dense layer on the inner surface and a porous layer on the layers other than the dense layer, the porosity is 60 to 90%, the overall mass transfer coefficient of myoglobin is at least 0.003 cm / min in the water-based system, and in the bovine serum A hollow fiber membrane made of an ethylene-vinyl alcohol polymer, wherein the blocking rate of albumin is 97% or more.
    [2" claim-type="Currently amended] 2. The method according to claim 1, wherein at a blood flow rate of 200 mL / min and a dialysis flow rate of 500 mL / min, the removal rate of urea in a serum system of cattle per 1.6 m 2 of membrane area is at least 175 mL / min and the removal rate of β 2 -microglobulin is Hollow fiber membrane of 35 mL / min or more.
    [3" claim-type="Currently amended] The hollow fiber membrane according to claim 1 or 2, wherein the hollow fiber membrane has a porosity of 30% or more at a depth of 1 m from the inner surface, and a diameter of 5 to 50 nm of a nozzle for forming the dense layer.
    [4" claim-type="Currently amended] A method of producing a hollow fiber membrane made of ethylene-vinyl alcohol, comprising the steps of: extruding a dope containing ethylene-vinyl alcohol and a solvent from a dual regeneration nozzle, in which a hollow forming agent is poured into the dual regeneration nozzle, The dope is transparent and uniform at high temperatures but phase separation occurs at lower temperatures); Passing the hollow fiber membrane extruded from the dual regeneration nozzle through air; And thereafter introducing the hollow fiber membrane into the water bath, wherein the air through which the hollow fiber membrane extruded from the temperature (T D , ° C.), the phase separation temperature (LST), and the dual regeneration nozzle of the dope forming the membrane passes. How the temperature (T A , ℃) satisfies the following relation:
    5 ≤ LST ≤ 40,
    T D ≤ LST + 20, and
    T A ≤ LST.
    类似技术:
    公开号 | 公开日 | 专利标题
    US5019261A|1991-05-28|Permeable, porous polymeric membrane with hydrophilic character methods for preparing said membranes and their use
    US6432309B1|2002-08-13|Polysulfone-base hollow-fiber hemocathartic membrane and processes for the production thereof
    US6074718A|2000-06-13|Self supporting hollow fiber membrane and method of construction
    CA2506229C|2011-08-02|Permselective membrane and process for manufacturing thereof
    US8262778B2|2012-09-11|Membrane post treatment
    EP0168783B1|1994-06-15|Asymmetric microporous hollow fibre, especially for hemodialysis, and process for making it
    JP2907883B2|1999-06-21|Method for producing microporous powder or microporous compact
    US4629563A|1986-12-16|Asymmetric membranes
    CA1304897C|1992-07-14|Porous membrane
    ES2378401T3|2012-04-12|Ultrafiltration membrane
    JP4355655B2|2009-11-04|Functional porous fiber
    US4073733A|1978-02-14|PVA membrane and method for preparing the same
    KR101162403B1|2012-07-04|Gas separation membrane
    US4279752A|1981-07-21|Polyvinyl alcohol semi-permeable membrane and method for producing same
    US5084173A|1992-01-28|Hydrophilic composite porous membrane, a method of producing the plasma separator
    EP0828553B1|2001-07-04|Synthetic separation diaphragm
    US5006247A|1991-04-09|Asymmetric porous polyamide membranes
    JP4898797B2|2012-03-21|Microfiltration membrane with improved filtration behavior
    US5145583A|1992-09-08|Asymmetric semipermeable membrane for the treatment of biological fluids
    EP0299381B1|1993-02-10|Membrane-type artificial lung and method of using it
    US4439322A|1984-03-27|Polymethyl methacrylate membrane
    EP0888211B1|2004-11-03|Highly porous polyvinylidene difluoride membranes
    JP3328394B2|2002-09-24|Composite microporous membrane
    KR101015479B1|2011-02-22|Membrane and use thereof
    JP4601699B2|2010-12-22|Highly porous poly | membrane
    同族专利:
    公开号 | 公开日
    CN1306883A|2001-08-08|
    TW524715B|2003-03-21|
    KR100557264B1|2006-03-07|
    CN1198679C|2005-04-27|
    ES2241692T3|2005-11-01|
    US6514409B2|2003-02-04|
    EP1134019A2|2001-09-19|
    US20010015335A1|2001-08-23|
    EP1134019B1|2005-07-06|
    EP1134019A3|2002-09-18|
    DE60111791D1|2005-08-11|
    DE60111791T2|2006-04-27|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    法律状态:
    2000-02-04|Priority to JP2000027751
    2000-02-04|Priority to JP2000-27751
    2001-02-01|Application filed by 나카무라 하사오, 가부시키가이샤 구라레
    2001-08-20|Publication of KR20010078245A
    2006-03-07|Application granted
    2006-03-07|Publication of KR100557264B1
    优先权:
    申请号 | 申请日 | 专利标题
    JP2000027751|2000-02-04|
    JP2000-27751|2000-02-04|
    [返回顶部]